Guidelines improve general trend of lowered cholesterol levels in type 2 diabetes patients in spite of low adherence

Scandinavian Journal of Public Health
E FhärmL Weinehall

Abstract

New guidelines were introduced in Sweden in 1999 to reduce the risk of cardiovascular disease among diabetes patients. The impact of the new guidelines on lipid levels in a diabetes patient population has not been extensively studied. Our aim was to study whether the introduction of treatment goals for dyslipidaemia was reflected in lower cholesterol levels in patients with diabetes in a general population. In a population of 59,338 individuals, 971 (1.6%) had diabetes. All subjects were 40, 50 or 60 years of age and participated in the Vasterbotten Intervention Programme in 1995-2004. Cholesterol levels and use of lipid-lowering drugs were measured, and trends in cholesterol levels were analysed before and after the guidelines were introduced in 1999. In this effectiveness study, there was a marked decrease in mean plasma total cholesterol levels among patients with diabetes (5.79 (+/- 1.21) mmol/1 in 1995-1999 and 5.07 (+/- 1.00) mmol/1 in 2000-2004 (p<0.001)) as well as in the non-diabetic population (5.79 (+/-1.15) mmol/1 and 5.41 (+/-1.07) mmol/1 (p<0.001)). The trend in diabetes patients was influenced by increased use of lipid-lowering agents, even though only 25.3% (male/female 26.8%/23.2%) of the diabetes patients rece...Continue Reading

References

Apr 15, 1994·American Journal of Epidemiology·R KehoeL T Chylack
Jan 28, 1998·Scandinavian Journal of Primary Health Care·I HetlevikK Midthjell
Jun 3, 1998·Diabetic Medicine : a Journal of the British Diabetic Association·C M FlorkowskiP J Graham
Aug 26, 2000·Journal of Diabetes and Its Complications·J B Marks, P Raskin
Jan 5, 2002·International Journal of Epidemiology·A EvansUNKNOWN WHO MONICA Project
May 30, 2002·The American Journal of Medicine·Richard W GrantJames B Meigs
Aug 28, 2002·Archives of Internal Medicine·Peter W F WilsonWilliam B Kannel
Oct 3, 2002·Diabetic Medicine : a Journal of the British Diabetic Association·M EliassonB Stegmayr
Oct 3, 2002·Journal of Hypertension·Lars WeinehallLars H Lindholm
Jan 31, 2003·The New England Journal of Medicine·Peter GaedeOluf Pedersen
May 20, 2003·Diabetic Medicine : a Journal of the British Diabetic Association·C CarrollT Dornan
Dec 9, 2003·Scandinavian Journal of Public Health. Supplement·Jan-Håkan JanssonTorbjörn Messner
Jun 30, 2004·Diabetes Research and Clinical Practice·Francisco Javier del Cañizo-Gómez, María Natividad Moreira-Andrés

❮ Previous
Next ❯

Citations

Mar 27, 2010·Global Health Action·Margareta NorbergLars Weinehall
Nov 18, 2008·Annales Françaises D'anesthèsie Et De Rèanimation·O LeroyUNKNOWN groupe AmarCand
Dec 3, 2009·Critical Pathways in Cardiology·Esteban GandaraAllen Kachalia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.